Evidence map›Paper›PMID 36259388›Full record

Observational studyCirculation. Heart failure2023

Racial Inequities in Access to Ventricular Assist Device and Transplant Persist After Consideration for Preferences for Care: A Report From the REVIVAL Study.

Thomas M Cascino, Monica M Colvin, David E Lanfear, Blair Richards, Shokoufeh Khalatbari, Douglas L Mann, Wendy C Taddei-Peters, Neal Jeffries, Daphne C Watkins, Garrick C Stewart and 2 more

Registry-linked trialOpen access · bronzeAbstract readObservational Study
In one paragraph

Observational study in Circulation. Heart failure, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01369407 (REVIVE-IT Registry), which is not on this map. Cited by 36 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 3 pooled it
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01369407 completednot on this map

REVIVE-IT Registry (REVIVAL: Registry Evaluation of Vital Information For VADs in Ambulatory Life)

Typeobservational_patient_registrySponsorUniversity of MichiganRan2015 to 2018Enrolled400ConditionsCongestive Heart FailureArmsNo Intervention
3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 3 syntheses or guidelines pooled it, 59 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Disparities in heart transplant survival and graft rejection outcomes persist in the modern era: a call to race towards a more equitable future.European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery · 2025
    Article
  16. Article
  17. Review
  18. Impact of Social Determinants of Health on Cardiovascular Disease.Journal of the American Heart Association · 2025
    Review
  19. Advancing Health Equity in the Cardiovascular Device Life Cycle.Circulation. Cardiovascular quality and outcomes · 2025
    Review
  20. OPTN/SRTR 2023 Annual Data Report: Heart.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Thomas M CascinoDivision of Cardiovascular Disease (T.M.C., M.M.C., K.D.A.), University of Michigan, Ann Arbor.ORCID 0000-0003-3779-0790
Monica M ColvinDivision of Cardiovascular Disease (T.M.C., M.M.C., K.D.A.), University of Michigan, Ann Arbor.
David E LanfearHenry Ford Hospital, Detroit, MI (D.E.L.).ORCID 0000-0001-6471-1483
Blair RichardsMichigan Institute for Clinical and Health Research (B.R., S.K.), University of Michigan, Ann Arbor.
Shokoufeh KhalatbariMichigan Institute for Clinical and Health Research (B.R., S.K.), University of Michigan, Ann Arbor.
Douglas L MannWashington University School of Medicine, St. Louis, MO (D.L.M.).ORCID 0000-0002-2516-0145
Wendy C Taddei-PetersNational Heart, Lung, and Blood Institute, Bethesda, MD (W.C.T.-P., N.J.).ORCID 0000-0002-7989-1752
Neal JeffriesNational Heart, Lung, and Blood Institute, Bethesda, MD (W.C.T.-P., N.J.).
Daphne C WatkinsSchool of Social Work (D.C.W.), University of Michigan, Ann Arbor.ORCID 0000-0002-6350-7891
Garrick C StewartBrigham and Women's Hospital, Boston, MA (G.C.S.).
Keith D AaronsonDivision of Cardiovascular Disease (T.M.C., M.M.C., K.D.A.), University of Michigan, Ann Arbor.ORCID 0000-0003-1538-576X
REVIVAL Investigators
University of Michigan · USNational Heart Lung and Blood Institute · USBrigham and Women's Hospital · USHenry Ford Hospital · USWashington University in St. Louis · US

Funding

Michigan Institute for Clinical and Health Research (MICHR)UL1TR002240 · NCATS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LUMENG, JULIE C, MASHOUR, GEORGE ALEXANDER · 2017 to 2022
$54.9M
Training to Advance Care Through Implementation Science in Cardiac And Lung Illnesses (TACTICAL)K12HL138039 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BARNES, GEOFFREY DOUGLAS, PRESCOTT, HALLIE CHRISTINE · 2017 to 2021
$3.1M
NCATS NIH HHS UL1 TR002240NHLBI NIH HHS HHSN268201100026CNHLBI NIH HHS K12 HL138039
6 · The paper itself

Abstract

backgroundRacial disparities in access to advanced therapies for heart failure (HF) patients are well documented, although the reasons remain uncertain. We sought to determine the association of race on utilization of ventricular assist device (VAD) and transplant among patients with access to care at VAD centers and if patient preferences impact the effect.

methodsWe performed an observational cohort study of ambulatory chronic systolic HF patients with high-risk features and no contraindication to VAD enrolled at 21 VAD centers and followed for 2 years in the REVIVAL study (Registry Evaluation of Vital Information for VADs in Ambulatory Life). We used competing events cause-specific proportional hazard methodology with multiple imputation for missing data. The primary outcomes were (1) VAD/transplant and (2) death. The exposures of interest included race (Black or White), additional demographics, captured social determinants of health, clinician-assessed HF severity, patient-reported quality of life, preference for VAD, and desire for therapies.

resultsThe study included 377 participants, of whom 100 (26.5%) identified as Black. VAD or transplant was performed in 11 (11%) Black and 62 (22%) White participants, although death occurred in 18 (18%) Black and 36 (13%) White participants. Black race was associated with reduced utilization of VAD and transplant (adjusted hazard ratio, 0.45 [95% CI, 0.23-0.85]) without an increase in death. Preferences for VAD or life-sustaining therapies were similar by race and did not explain racial disparities.

conclusionsAmong patients receiving care by advanced HF cardiologists at VAD centers, there is less utilization of VAD and transplant for Black patients even after adjusting for HF severity, quality of life, and social determinants of health, despite similar care preferences. This residual inequity may be a consequence of structural racism and discrimination or provider bias impacting decision-making. REGISTRATION: URL: https://www. CLINICALTRIALS: gov; Unique identifier: NCT01369407.

Indexed as

Heart-Assist DevicesHeart FailureHeart Failure, SystolicHumansQuality of LifeRisk Factorsdecision-makinghealthcare disparitiesheart failuresocial determinants of healthventricular assist device

Identifiers

PMID36259388
PMCPMC9851944
OpenAlexW4306780857

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.